Centene Corporation Investors Suffer Losses Due to Alleged Securities Fraud

Strategic Insights -

Centene Corporation ("Centene" or the "Company") (NYSE: CNC) investors were allegedly misled by the company's positive statements regarding the company's enrollment and morbidity rates. According to the complaint, from December 12, 2024 to June 30, 2025, defendants provided false and misleading statements to investors while concealing material adverse facts. The truth about the company's 2025 Health Insurance Marketplace performance was only revealed on July 1, 2025, when Centene issued a press release withdrawing its 2025 guidance. This led to a significant decline in the company's stock price, from $56.65 per share on July 1, 2025 to $33.78 per share on July 2, 2025, a decline of 40.4%.

Key Takeaways:

  • Centene investors suffered losses due to allegedly false and misleading statements made by the company from December 12, 2024 to June 30, 2025.
  • Defendants concealed material adverse facts concerning the true state of Centene's enrollment and morbidity rates during the class period.
  • Centene issued a press release on July 1, 2025 withdrawing its 2025 guidance due to lower-than-expected market growth across 22 states, or 72% of the Company's marketplace membership.
  • The company's stock price declined from $56.65 per share on July 1, 2025 to $33.78 per share on July 2, 2025, a decline of 40.4%.
  • The class action lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by the alleged securities fraud.
  • Investors have until September 8, 2025 to request that the Court appoint them as lead plaintiff.

Statistics:

  • Date range in which alleged securities fraud occurred: December 12, 2024 - June 30, 2025.
  • Stock price decline on July 2, 2025: 40.4% (from $56.65 to $33.78 per share).
  • Total percentage of marketplace membership affected by lower market growth: 72%.
  • Number of states in which Centene's market growth was lower than expected: 22.
  • Amount of Centene's previously issued guidance withdrawn: approximately $1.8 billion.
  • Adjusted diluted earnings per share (EPS) withdrawn: $2.75.

Sources:

  • Globe Newswire, "Levi & Korsinsky, LLP Notifies Investors in Centene Corporation (NYSE: CNC) of Class Action Lawsuit" (July 17, 2025).
  • Comtex, "Centene Corporation (CNC) news and press releases" (July 17, 2025).